135 related articles for article (PubMed ID: 24649554)
21. The genetics of uveal melanoma: an emerging framework for targeted therapy.
Harbour JW
Pigment Cell Melanoma Res; 2012 Mar; 25(2):171-81. PubMed ID: 22268848
[TBL] [Abstract][Full Text] [Related]
22. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
[TBL] [Abstract][Full Text] [Related]
23. Metastatic uveal melanoma.
Singh AD; Borden EC
Ophthalmol Clin North Am; 2005 Mar; 18(1):143-50, ix. PubMed ID: 15763199
[TBL] [Abstract][Full Text] [Related]
24. Uveal melanoma: a rare malignancy.
Gragoudas ES; Egan KM
Ophthalmology; 2000 Aug; 107(8):1441-2. PubMed ID: 10919884
[No Abstract] [Full Text] [Related]
25. What hope for the future? GNAQ and uveal melanoma.
Sisley K; Doherty R; Cross NA
Br J Ophthalmol; 2011 May; 95(5):620-3. PubMed ID: 21378004
[TBL] [Abstract][Full Text] [Related]
26. The Ashton Lecture. Uveal melanoma: the past, the present and the future.
Rennie IG
Eye (Lond); 1997; 11 ( Pt 2)():255-64. PubMed ID: 9349422
[No Abstract] [Full Text] [Related]
27. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
[TBL] [Abstract][Full Text] [Related]
28. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
[TBL] [Abstract][Full Text] [Related]
29. Obstacles to improving outcomes in the treatment of uveal melanoma.
Tsai KK; Bollin KB; Patel SP
Cancer; 2018 Jul; 124(13):2693-2703. PubMed ID: 29579316
[TBL] [Abstract][Full Text] [Related]
30. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
31. Uveal Melanoma UK National Guidelines.
Nathan P; Cohen V; Coupland S; Curtis K; Damato B; Evans J; Fenwick S; Kirkpatrick L; Li O; Marshall E; McGuirk K; Ottensmeier C; Pearce N; Salvi S; Stedman B; Szlosarek P; Turnbull N;
Eur J Cancer; 2015 Nov; 51(16):2404-12. PubMed ID: 26278648
[TBL] [Abstract][Full Text] [Related]
32. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L
Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016
[TBL] [Abstract][Full Text] [Related]
33. [A case of hepatic metastases from uveal melanoma treated effectively by transcatheter arterial chemoembolization with cisplatin and degradable starch microspheres].
Sakane M; Sato Y; Yamaura H; Kato M; Kanamoto T; Tomozawa Y; Inaba Y; Muro K
Gan To Kagaku Ryoho; 2012 Jun; 39(6):959-61. PubMed ID: 22705692
[TBL] [Abstract][Full Text] [Related]
34. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.
Smith SL; Damato BE; Scholes AG; Nunn J; Field JK; Heighway J
Br J Cancer; 2002 Nov; 87(11):1308-13. PubMed ID: 12439722
[TBL] [Abstract][Full Text] [Related]
35. The molecular classification of uveal melanocytic lesions: an important discovery in context.
Folberg R
J Mol Diagn; 2010 Jul; 12(4):391-3. PubMed ID: 20522635
[TBL] [Abstract][Full Text] [Related]
36. [Genomic techniques used in uveal melanoma: a literature review].
Abi-Ayad N; Kodjikian L; Couturier J
J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
38. Uveal melanoma trapped in the temple of doom.
Shields CL; Ganguly A; O'Brien J; Sato T; Shields JA
Am J Ophthalmol; 2012 Aug; 154(2):219-21. PubMed ID: 22813447
[No Abstract] [Full Text] [Related]
39. Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival.
Lake SL; Damato BE; Kalirai H; Dodson AR; Taktak AF; Lloyd BH; Coupland SE
Am J Pathol; 2013 Mar; 182(3):678-87. PubMed ID: 23357503
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]